Navigation Links
Vasogen Announces First Quarter 2008 Results
Date:4/3/2008

(6,352) 19,930

Cash and cash equivalents, beginning

of period 23,545 30,427 -

-------------------------------------------------------------------------

Cash and cash equivalents, end of

period $ 19,930 $ 24,075 $ 19,930

-------------------------------------------------------------------------

-------------------------------------------------------------------------


'/>"/>
SOURCE Vasogen Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Vasogen Announces Third Quarter Conference Call and Webcast of Bio InvestorForum 2007 Presentation
2. Vasogen Announces Third Quarter 2007 Results
3. Vasogen to Webcast Presentations at Three Upcoming Healthcare Conferences
4. Vasogen Provides an Update on ACCLAIM-II Preparations
5. Vasogen and Grupo Ferrer Announce Initial Roll-out of Celacade - New Therapy for Chronic Heart Failure
6. Vasogen to Conduct Year-end 2007 Conference Call
7. Vasogen Announces 2007 Year-End Results
8. The Lancet Publishes Vasogens ACCLAIM Results
9. Vasogens Research Published in European Journal of Neuroscience
10. Vasogen to Present at the BIO CEO & Investor Conference and Participate on the Non-Cancer Immunotherapy Panel
11. Vasogen Provides Update on ACCLAIM II Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... ... July 29, 2015 , ... Costello served as Lead Levee Design Engineering ... the Orange County, Texas area from future storm surge flooding, such as occurred in ... potential levee alignment alternatives for providing protection, Costello also balanced socio-economic and environmental ...
(Date:7/28/2015)... July 29, 2015 A ... acquiring, rapidly developing and commercialising innovative medicines to ... Highly experienced management team; blue chip ...   Mereo BioPharma Group Ltd ("Mereo"), a recently-formed ... ( c. £76.5m), gross, from blue chip institutional investors ...
(Date:7/28/2015)... 2015 People with a common form of ... and sometimes profound improvements in their hearing and understanding ... a new multicenter study led by specialists at NYU ... online ahead of print in the journal The Laryngoscope July ... in the United States implanted ...
(Date:7/28/2015)... , July 21, 2015 Research ... addition of the "Biomedical Refrigerators and Freezers ... Trends and Forecast 2014 - 2022" report ... biomedical refrigerators and freezers market has been segmented ... centers, blood banks, and others. The others segment ...
Breaking Biology Technology:Preventing Storm Surge Flooding in Houston 2Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 2Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 3Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 4Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 5Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 6Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 7Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 8Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 9Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 10Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 11Hybrid Cochlear Implants For Common Form Of Hearing Loss May Benefit Millions 2Hybrid Cochlear Implants For Common Form Of Hearing Loss May Benefit Millions 3Biomedical Refrigerators and Freezers Market Report - Global Industry Analysis 2015 2Biomedical Refrigerators and Freezers Market Report - Global Industry Analysis 2015 3
... IRVINE, Calif., Oct. 15 The increased emphasis ... more costly medical,product development programs and requires rapid, ... appropriately. Expertise,to effect constructive change can be found ... protect our clients from compliance errors,that can lead ...
... from the Swedish medical university Karolinska Institutet reveals completely ... that contradict previous findings. The studies, which are published ... that hair follicle stem cells can divide actively and ... "The stem cells don,t behave at all in the ...
... Vineland Research and Innovation,Centre, an independent, not-for-profit ... horticultural science and innovation in Ontario,today announced ... the new role of,Research Chair, Molecular Breeding ... is determined to become a beacon of ...
Cached Biology Technology:Ground Zero Pharmaceuticals Announces Expansion of Regulatory and Product Development Consulting Services 2Ground Zero Pharmaceuticals Announces Expansion of Regulatory and Product Development Consulting Services 3Vineland Welcomes Dr. Daryl Somers as Research Chair, Molecular Breeding and Biotechnology 2
(Date:6/26/2015)... , June 26, 2015 ATL Technology, LLC, ... devices with specialties in single use solutions, headquartered in ... MedConx, Inc. (a California corporation with ... San Jose, Costa Rica ). ... Costa Rica with ATL Technology,s existing facility in ...
(Date:6/25/2015)... June 25, 2015  TAKE Solutions Ltd., a global ... the United States Patent and Trademark Office (USPTO) for ... leverages TAKE Solutions, Clinical Accelerators to reduce the time ... compared to standardization without the accelerators), thus reducing time ... At the heart of the patented Clinical ...
(Date:6/24/2015)... 24, 2015  Synaptics Inc. (NASDAQ: SYNA ... today announced that Sharp has selected its industry-leading ... for its latest flagship smartphone device, the AQUOS ... million shipments of its fingerprint ID sensor technology, ... scalability and leadership in the biometrics market through ...
Breaking Biology News(10 mins):ATL Technology Announces Acquisition of MedConx, Inc. and Expanded Global Footprint 2TAKE Solutions Awarded Patent By USPTO 2Synaptics Brings Natural ID Technology to Sharp's Newest Flagship Smartphone 2
... children, the rates of chronic health conditions overall, and asthma ... 14 years, although the rate of obesity did increase, according ... JAMA . Changes in perinatal care in the 1990s ... less than 2.2 lbs.). "The school-aged outcomes for ...
... For thousands of years, bakers and brewers have relied ... Yet, University of Wisconsin-Madison researchers eager to harness this talent ... through sugars, these budding microbes can be picky eaters. ... the National Academy of Sciences , a Great Lakes Bioenergy ...
... Aware, Inc. (NASDAQ: AWRE ), a leading supplier of ... second quarter ended June 30, 2011.   Revenue for ... 19% compared to $5.0 million in the same quarter last year. ... or $0.01 per diluted share. These results compared to a net ...
Cached Biology News:Rate of chronic health problems for low-birth-weight children does not increase in adolescence 2 Novel gene increases yeast's appetite for plant sugars 2Aware, Inc. Reports Second Quarter 2011 Financial Results 2Aware, Inc. Reports Second Quarter 2011 Financial Results 3Aware, Inc. Reports Second Quarter 2011 Financial Results 4Aware, Inc. Reports Second Quarter 2011 Financial Results 5
... is used to inhibit photobleaching ... microscopy. The unique formulation effectively ... variety of fixed specimens stained ... sulforhodamine 101, coumarin, DAPI, propidium ...
...
Mouse polyclonal antibody to QDPR - quinoid dihydropteridine reductase...
... kit provides high-pressure tubing for use ... other chromatography systems. The kit includes ... orange PEEK tubing for the installation ... system running at flow rates less ...
Biology Products: